Crescent Biopharma, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $14.6M | $142.8M | $137.0M |
| FY2021 | $12.7M | $94.3M | $90.3M |
| FY2022 | $8.9M | $51.8M | $47.9M |
| FY2023 | $6.9M | $45.3M | $41.8M |
| FY2024 | $47.1M | $35.6M | $0 |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $14.6M | $142.8M | $137.0M |
| FY2021 | $12.7M | $94.3M | $90.3M |
| FY2022 | $8.9M | $51.8M | $47.9M |
| FY2023 | $6.9M | $45.3M | $41.8M |
| FY2024 | $47.1M | $35.6M | $0 |